We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PACS:NYSEPACS Group, Inc. analysis

Data as of Sep 15, 2026 - not real-time

Latest price
$44.55
Risk: medium
5/10Medium risk

Summary

PACS Group, Inc. is priced at $44.55, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 3.2%. Relative strength is 53.2 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $41.76 and resistance at $45.85.
On valuation the read is fair — earnings multiple of 26.1 versus a 30.0 sector average, below the peer group. Consensus targets land 32.4% above where the shares trade now. Revenue is growing at 9.1% on a 4.8% profit margin.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 34.2%, a beta of 0.36 and a maximum drawdown of 27.9%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.

Top market events

  • Updated Aug 4, 2026 0 SALT LAKE CITY-- BUSINESS WIRE --Aug 4, 2026-- PACS Group, Inc.
  • Yahoo Finance1monPACS Group, Inc. PACS Q2 FY2026 earnings call transcriptPACS delivered robust Q2 2026 results with...
  • Yahoo Finance1monPACS Group, Inc. PACS Surpasses Q2 Earnings and Revenue EstimatesThe above button links to Coinbase....

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 38.29
  • MACD momentum is positive
  • Maximum drawdown of 27.9%

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • P/E of 26.1 versus sector average of 30.0
  • Trading above the 200-day average of 38.29
  • Analyst targets imply +32.4% versus the current price

Long term

> 3 years

Positive

Model confidence5/105 out of 10

Key factors

  • P/E of 26.1 versus sector average of 30.0
  • Analyst targets imply +32.4% versus the current price
  • Return on equity of 27.9%

Key metrics

Financial health

Revenue Growth9.10%
Profit Margin4.85%
P/E Ratio26.1
ROE27.92%
ROA4.60%
Debt/Equity305.26
P/B Ratio6.4
Op. Cash Flow$573.2M
Free Cash Flow$378.3M
Industry P/E30.0

Technical analysis

TrendNeutral
RSI53.2
Support$41.76
Resistance$45.85
MA 20$43.77
MA 50$44.78
MA 200$38.29
MACDBullish
VolumeIncreasing
Fear & Greed Index90.3

Valuation

Fair Value$22.77
Target Price$59.00
Upside/Downside32.44%
GradeFair
TypeGrowth

Risk assessment

Beta0.36
Volatility34.21%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.